{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:14:11Z","timestamp":1760188451569},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[1985,1,1]],"date-time":"1985-01-01T00:00:00Z","timestamp":473385600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[1985]]},"DOI":"10.1007\/bf00544355","type":"journal-article","created":{"date-parts":[[2004,11,19]],"date-time":"2004-11-19T05:57:08Z","timestamp":1100843828000},"page":"387-390","source":"Crossref","is-referenced-by-count":13,"title":["Drug acetylation and expression of lupus erythematosus"],"prefix":"10.1007","volume":"28","author":[{"given":"J. R.","family":"Marsden","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. G. F.","family":"Mason","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. R.","family":"Coburn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. D.","family":"Rawlins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Shuster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/jmg.6.4.405","volume":"6","author":"DAP Evans","year":"1969","unstructured":"Evans DAP (1969) An improved and simplified method for detecting the acetylator phenotype. J Med Genet 6: 405","journal-title":"J Med Genet"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/art.1780220118","volume":"22","author":"E Fishbein","year":"1979","unstructured":"Fishbein E, Alarcon-Segovia D (1979) Slow acetylation phenotype in systemic lupus erythematosus. Arthritis Rheum 22: 95","journal-title":"Arthritis Rheum"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1002\/art.1780200309","volume":"20","author":"B Foad","year":"1977","unstructured":"Foad B, Litwin A, Zimmer H, Hess EV (1977) Acetylator phenotype in systemic lupus erythematosus. Arthritis Rheum 20: 815","journal-title":"Arthritis Rheum"},{"key":"CR4","first-page":"181","volume":"124","author":"P Godeau","year":"1973","unstructured":"Godeau P, Aubert M, Lambert J-C, Herreman G (1973) Lupus erythemateaux dissemine taux d'isonizide actif. Ann Med Interne (Paris) 124: 181?186","journal-title":"Ann Med Interne"},{"key":"CR5","first-page":"126","volume":"8","author":"EA Johannson","year":"1976","unstructured":"Johannson EA, Mustakallio KK, Mattila MM, Tulikainen A (1976) Cutaneous reactions to drugs, acetylation phenotype and HLA antigens in patients with and without systemic lupus erythematosus. Ann Clin Res 8: 126?128","journal-title":"Ann Clin Res"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1136\/ard.38.2.171","volume":"38","author":"DH Lawson","year":"1979","unstructured":"Lawson DH, Henry DA, Lowe J, Reavey P, Rennie JAN, Solomon A (1979) Acetylator phenotype in spontaneous SLE and rheumatoid arthritis. Ann Rheum Dis 38: 171?173","journal-title":"Ann Rheum Dis"},{"key":"CR7","first-page":"694","volume":"109","author":"JR Marsden","year":"1983","unstructured":"Marsden JR, Mason GGF, Coburn PR, Rawlins MD, Shuster S (1983) Acetylator phenotype and discoid lupus erythematosus. Br J Dermatol 109: 694","journal-title":"Br J Dermatol"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.0954-6820.1977.tb15685.x","volume":"201","author":"L Molin","year":"1977","unstructured":"Molin L, Lavssan R, Karlsson E (1977) Evaluation of the sulphapyridine acetylator phenotyping test in healthy subjects and in patients with cardiac and renal diseases. Acta Med Scand 201: 217?222","journal-title":"Acta Med Scand"},{"key":"CR9","first-page":"777","volume":"22","author":"RJ Morris","year":"1979","unstructured":"Morris RJ, Freed CR, Kohler PF (1979) Drug acetylation phenotype unrelated to development of spontaneous systemic lupus erythematosus arthritis. Rheum 22: 777?780","journal-title":"Rheum"},{"key":"CR10","first-page":"71","volume":"2","author":"MM Reidenberg","year":"1974","unstructured":"Reidenberg MM, Martin JH (1974) Acetylator phenotype of patients with systemic lupus erythematosus. Drug Metab Dispos 2: 71?73","journal-title":"Drug Metab Dispos"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/art.1780230508","volume":"23","author":"MM Reidenberg","year":"1980","unstructured":"Reidenberg MM, Levy M, Drayer DE, Tylber-Katz E, Robbins WC (1980) Acetylator phenotype in idiopathic systemic lupus erythematosus. Arthritis Rheum 23: 569?573","journal-title":"Arthritis Rheum"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.0954-6820.1976.tb08248.x","volume":"200","author":"I Strandberg","year":"1976","unstructured":"Strandberg I, Boman G, Hassler L, Sjoqvist F (1976) Acetylator phenotype in patients with hydralazine induced lupoid syndrome. Acta Med Scand 200: 367?371","journal-title":"Acta Med Scand"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/art.1780251101","volume":"25","author":"EM Tan","year":"1982","unstructured":"Tan EM, Cohen AS, Fries F, Magi AT, McShane DJ, Rothfield NF, Schafer JG, Talal N, Winchester RJ (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25: 1271?1277","journal-title":"Arthritis Rheum"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"118","DOI":"10.2165\/00003088-198106020-00003","volume":"6","author":"JP Uetrecht","year":"1981","unstructured":"Uetrecht JP, Woosley RL (1981) Acetylator phenotype and lupus erythematosus. Clin Pharmacokinet 6: 118?134","journal-title":"Clin Pharmacokinet"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/art.1780210203","volume":"21","author":"J Vansant","year":"1978","unstructured":"Vansant J, Woosley RL, John JT, Sergent JS (1978) Normal distribution of acetylation phenotypes in systemic lupus erythematosus. Arthritis Rheum 21: 192?195","journal-title":"Arthritis Rheum"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1056\/NEJM197805252982101","volume":"298","author":"RL Woosley","year":"1978","unstructured":"Woosley RL, Drayer DE, Reidenberg MM, Nies AS, Carr K, Oates JA (1978) Effect of acetylator phenotype on the rate at which procainamide induces antinuclear antibodies and the lupus syndrome. N Engl J Med 298: 1157?1159","journal-title":"N Engl J Med"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00544355.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00544355\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00544355","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,4]],"date-time":"2019-04-04T22:36:20Z","timestamp":1554417380000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00544355"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1985]]},"references-count":16,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1985]]}},"alternative-id":["BF00544355"],"URL":"https:\/\/doi.org\/10.1007\/bf00544355","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[1985]]}}}